Wyeth CEO to Get $53 Million Under Pfizer Inc. Deal

March 30, 2009 |

1 min read

AP -- Wyeth's chief executive is in line to get a whopping $53 million in severance payments if the drugmaker's pending acquisition by Pfizer Inc. is completed, according to a regulatory filing Friday.

Mergers & acquisitions

Pfizer

MORE ON THIS TOPIC

Illustration showing hands holding arrow that goes up and down a few times and ends up in upward direction

Mergers & acquisitions

Rumors of Eli Lilly Buyout Send Nektar’s Shares Spiking

October 20, 2025

·

2 min read

·

Tristan Manalac

Pleasanton, CA, USA - Feb 21, 2024: Exterior view of the headquarters of Roche Molecular Diagnostics (RMD) in Pleasanton, California. F. Hoffmann-La Roche AG is a Swiss pharmaceutical company.

Antibody-drug conjugate (ADC)

Roche Inks Another China ADC Pact With $1.5B Hansoh Bet

October 17, 2025

·

2 min read

·

Tristan Manalac

Gentilly, France, March 21, 2021: Exterior view of the Sanofi headquarters building. Sanofi is a French multinational company specializing in the health sector

Autoimmune disease

Sanofi Joins With EVOQ in $500M Autoimmune Alliance

October 16, 2025

·

2 min read

·

Tristan Manalac

Facade of Novo Nordisk's office in Fremont, California

Rare diseases

Novo Offers up to $2.1B for Omeros’ Complement Drug To Expand Rare Disease Work

October 15, 2025

·

2 min read

·

Dan Samorodnitsky